Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Eton Pharmaceuticals Inc (ETON)
NASDAQ:ETON
RESEARCH TOOLSreports
Holding ETON?
Track your performance easily
Earnings Data
Report Date
Mar 13, 2025TBA Not Confirmed
Period Ending
2024 (Q4)Consensus EPS Forecast
-$0.01Last Year’s EPS
-$0.09Same Quarter Last Year
Moderate Buy
Based on 2 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:Nov 12, 2024
|% Change Since: 37.08%
|Next Earnings Date:Mar 13, 2025
Earnings Call Sentiment|Positive
The earnings call was predominantly positive, highlighting significant revenue growth, a strategic acquisition, and achieving profitability ahead of schedule. While there were challenges such as increased administrative expenses and higher discontinuation rates for a specific product, they were outweighed by the company's overall achievements and strategic advancements.Company Guidance
During the Eton Pharmaceuticals Q3 2024 earnings call, significant guidance was provided, highlighting the company's strategic and financial advancements. The company's three-pillar strategy, focusing on organic growth, internal pipeline advancement, and value-creating business development, led to a 40% year-over-year increase in product sales, marking the 15th consecutive quarter of sequential revenue growth. Eton achieved a key milestone by reaching positive GAAP net income, one quarter ahead of its target. The company is on track to close an asset purchase agreement for Increlex, which aligns with its pediatric endocrinology focus. With plans for a sales force expansion and the anticipated launch of ET-400 by February 28, 2025, Eton aims to bolster its revenue trajectory. The CEO mentioned the company's goal to reach $100 million in revenue and a $1 billion market cap, driven by additions to its rare disease portfolio and strategic acquisitions. Eton concluded the quarter with $20.3 million in cash and generated $2.9 million in operating cash flow.Record-Breaking Revenue and Growth
Eton Pharmaceuticals delivered another record quarter of product sales with a 40% year-over-year increase. The growth was driven by strong increases in Alkindi Sprinkle and carglumic acid sales.
Achieved Positive GAAP Net Income
Eton achieved positive GAAP net income in the third quarter, reaching this milestone one quarter ahead of schedule.
FDA Review and Patent for ET-400
ET-400's new drug application was accepted for FDA review, with a PDUFA date set for February 28, 2025. Additionally, a second patent for ET-400 was granted, strengthening IP protection.
Increlex Acquisition
Eton signed an asset purchase agreement to acquire Increlex, a transformational opportunity expected to close by the end of the year.
Expansion and Realignment of Sales Force
Plans to expand and realign the sales force in 2025 to support Increlex and ET-400 were announced, indicating a strategic move to maximize revenue potential.
---
ETON Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
ETON Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
| Nov 12, 2024 | $9.17 | $10.60 | +15.59% |
| Aug 08, 2024 | $3.62 | $3.72 | +2.76% |
| May 09, 2024 | $3.44 | $3.43 | -0.29% |
| Mar 14, 2024 | $4.46 | $3.85 | -13.68% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does Eton Pharmaceuticals Inc (ETON) report earnings?
Eton Pharmaceuticals Inc (ETON) is schdueled to report earning on Mar 13, 2025, TBA Not Confirmed.
What is Eton Pharmaceuticals Inc (ETON) earnings time?
Eton Pharmaceuticals Inc (ETON) earnings time is at Mar 13, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is ETON EPS forecast?
ETON EPS forecast for the fiscal quarter 2024 (Q4) is -$0.01.
---
